HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiac performance in cats after administration of xylazine or xylazine and glycopyrrolate: echocardiographic evaluations.

Abstract
Cardiac performance was evaluated in 9 healthy cats sedated with xylazine. Each cat was evaluated echocardiographically before and after the administration of xylazine or xylazine and glycopyrrolate. Each cat was echocardiographically evaluated during manual restraint only (control value), after IM administration of 0.55 mg of xylazine/kg of body weight, after IM administration of 2.2 mg of xylazine/kg, and after IM administration of 0.011 mg of glycopyrrolate/kg followed 10 minutes later by IM administration of 2.2 mg of xylazine/kg. Echocardiographic indices of cardiac performance (fractional shortening, left ventricular wall amplitude, aortic amplitude, mitral valve E point septal separation) indicated a significant decrease (P less than 0.05) in the left ventricular function and heart rate after the small (0.55 mg/kg) and large (2.2 mg/kg) dosages of xylazine. With the administration of glycopyrrolate, the bradycardia was minimized, but cardiac performance was not improved. After administration of glycopyrrolate, cardiac performance decreased, but the decrease was not significant when compared with the ventricular performance of the cats after administration of the large dosage of xylazine. Compared with control values, the reduction in left ventricular function values associated with administration of xylazine or xylazine and glycopyrrolate was independent of the heart rate. Therefore, the alpha-2 adrenergic agonist xylazine has a marked depressive effect on cardiac performance in the cat, and premedication with glycopyrrolate may not completely alleviate the undesirable bradycardia, but may actually be detrimental to the cardiovascular system.
AuthorsN Dunkle, N S Moise, J Scarlett-Kranz, C E Short
JournalAmerican journal of veterinary research (Am J Vet Res) Vol. 47 Issue 10 Pg. 2212-6 (Oct 1986) ISSN: 0002-9645 [Print] United States
PMID3777649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Pyrrolidines
  • Thiazines
  • Xylazine
  • Glycopyrrolate
Topics
  • Animals
  • Cats (physiology)
  • Drug Therapy, Combination
  • Echocardiography
  • Female
  • Glycopyrrolate (administration & dosage, pharmacology)
  • Heart (drug effects, physiology)
  • Heart Rate (drug effects)
  • Injections, Intramuscular
  • Male
  • Pyrrolidines (pharmacology)
  • Random Allocation
  • Thiazines (pharmacology)
  • Xylazine (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: